冠心病患者经皮冠状动脉介入治疗术后合并焦虑抑郁机制及治疗的研究进展

doi:10.3969/j.issn.1006-5725.2023.21.026

Abstract

Abstract:

Percutaneous coronary intervention （PCI） is one of the most important therapeutic measures for coronary heart disease. It can quickly and effectively relieve coronary artery obstruction. Patients with coronary heart disease often suffer from the complication of emotional disorders like anxiety and depression. The incidence of anxiety and depression in patients having undergone PCI is significantly higher in those having not. But anxiety and depression can remarkably increase the major adverse cardiac events （MACE） in patients after PCI. This article reviews the associations， mechanisms and treatments of anxiety and depression after PCI.

Key words: coronary heart disease, anxiety, depression, percutaneous coronary intervention

CLC Number:

R541.4

Shan LONG,Xingde LIU,Tiantian LI,Yang ZOU,Haiyan ZHOU. Mechanisms and treatments of post⁃PCI anxiety and depression of patients with coronary heart disease： A review of literature[J]. The Journal of Practical Medicine, 2023, 39(21): 2850-2856.

References 58

1	中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要［J］. 中国循环杂志，2022，37（6）：553-578.
2	MARZILLI M， HUQI A， MORRONE D. Persistent angina： the Araba Phoenix of cardiology［J］. Am J Cardiovasc Drugs， 2010，10（）：27-32.
3	史金玉，王超，黄乐曦，等. 冠心病合并焦虑抑郁的治疗研究进展［J］. 世界中医药，2022，17（14）：2087-2091.
4	ELDERON L， SMOLDEREN K G， NA B， et al. Accuracy and prognostic value of American Heart Association： recommended depression screening in patients with coronary heart disease： data from the Heart and Soul Study［J］. Circ Cardiovasc Qual Outcomes， 2011，4（5）：533-540.
5	LI G， TIAN Y， ZHANG Q， et al. The Predictive Effect of Negative Psychological Emotions of Anxiety and Depression on the Poor Prognosis of CHD Patients with Stent Implantation and the Improvement of Clinical Intervention Measures［J］. Comput Math Methods Med， 2022， 2022： 2534277.
6	TROTTER R， GALLAGHER R， DONOGHUE J. Anxiety in patients undergoing percutaneous coronary interventions［J］. Heart Lung， 2011， 40（3）：185-192.
7	GU G， ZHOU Y， ZHANG Y， et al. Increased prevalence of anxiety and depression symptoms in patients with coronary artery disease before and after percutaneous coronary intervention treatment［J］. BMC Psychiatry， 2016， 16：259.
8	赖敏华，李静芝，陈凌，等. 冠心病患者PCI术后全因死亡率、再入院率及其影响因素分析［J］. 实用医学杂志，2020，36（6）：801-807.
9	KALA P， HUDAKOVA N， JURAJDA M， et al. Depression and Anxiety after Acute Myocardial Infarction Treated by Primary PCI［J］. PLoS One， 2016，11（4）：e0152367.
10	BORREGAARD B， NIELSEN S N， LASSEN J F， et al. The DenHeart group， Symptoms of depression at discharge after PCI are associated with an increased risk of 1-year mortality： findings from the national DenHeart study［J］. Eur Heart J， 2020， 41（Supplement_2）： ehaa946.3417.
11	VAN DIJK M R， UTENS E M， DULFER K， et al. Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up［J］. Eur J Prev Cardiol， 2016， 23（5）：552-558.
12	YANG X L， XIE W Y， CAI Y M， et al. Investigation of the Negative Emotions Exhibited in Patients with Coronary Heart Disease After PCI and Any Influencing Factors［J］. Psychol Res Behav Manag， 2022， 15：3027-3037.
13	CHRONISTER B N， GONZALEZ E， LOPEZ-PAREDES D， et al. Testosterone， estradiol， DHEA and cortisol in relation to anxiety and depression scores in adolescents［J］. J Affect Disord， 2021，294：838-846.
14	HAUGER R L， SAELZLER U G， PAGADALA M S， et al. The role of testosterone， the androgen receptor， and hypothalamic-pituitary-gonadal axis in depression in ageing Men［J］. Rev Endocr Metab Disord， 2022， 23（6）：1259-1273.
15	KANG D， YANG J W， CHOI W J， et al. Anxiety， Depression and Sleep Disturbance among Customer-Facing Workers［J］. J Korean Med Sci， 2019， 34（48）：e313.
16	FENG V， TUMATI S， WANG R， et al. The Relationship between Oxidative Stress and Subjective Sleep Quality in People with Coronary Artery Disease［J］. Brain Sci， 2022， 12（8）：1070.
17	XING C， ZHOU Y， XU H， et al. Sleep disturbance induces depressive behaviors and neuroinflammation by altering the circadian oscillations of clock genes in rats［J］. Neurosci Res， 2021， 171：124-132.
18	姬林娟，李星辉，孙小龙，等. 甘肃农村地区冠心病患者经皮冠状动脉介入治疗术后抑郁及焦虑状况调查［J］. 中国介入心脏病学杂志，2020，28（12）：700-704.
19	PAJĄK A， JANKOWSKI P， KOTSEVA K， et al. Depression， anxiety， and risk factor control in patients after hospitalization for coronary heart disease： the EUROASPIRE III Study［J］. Eur J Prev Cardiol， 2013， 20（2）：331-340.
20	何玮琳，祝颖，熊维，等. 冠心病PCI术后患者焦虑抑郁的影响因素分析［J］. 中华现代护理杂志，2022，28（35）：4958-4962.
21	HUANG P， YAN L， LI Z， et al. Potential shared gene signatures and molecular mechanisms between atherosclerosis and depression： Evidence from transcriptome data［J］. Comput Biol Med， 2023， 152：106450.
22	WANG Y， LIU W， XIAO Y， et al. Association of Apelin and Apelin Receptor Polymorphisms With the Risk of Comorbid Depression and Anxiety in Coronary Heart Disease Patients［J］. Front Genet， 2020， 11：893.
23	AL-QEZWENY M N， UTENS E M， DULFER K， et al. The association between type D personality， and depression and anxiety ten years after PCI［J］. Neth Heart J， 2016， 24（9）：538-543.
24	KUPPER N， DENOLLET J. Type D Personality as a Risk Factor in Coronary Heart Disease： a Review of Current Evidence［J］. Curr Cardiol Rep， 2018， 20（11）：104.
25	ADIBFAR A， SALEEM M， LANCTOT K L， et al. Potential Biomarkers for Depression Associated with Coronary Artery Disease： A Critical Review［J］. Curr Mol Med， 2016， 16（2）：137-164.
26	SCHUMANN A， HELBING N， RIEGER K， et al. Depressive rumination and heart rate variability： A pilot study on the effect of biofeedback on rumination and its physiological concomitants［J］. Front Psychiatry， 2022， 13：961294.
27	CHOI K W， JEON H J. Heart Rate Variability for the Prediction of Treatment Response in Major Depressive Disorder［J］. Front Psychiatry， 2020， 11：607.
28	QIU W， CAI X， ZHENG C， et al. Update on the Relationship Between Depression and Neuroendocrine Metabolism［J］. Front Neurosci， 2021， 15：728810.
29	MESHKAT S， ALNEFEESI Y， JAWAD M Y， et al. Brain-Derived Neurotrophic Factor （BDNF） as a biomarker of treatment response in patients with Treatment Resistant Depression （TRD）： A systematic review & meta-analysis［J］. Psychiatry Res， 2022， 317：114857.
30	LIBBY P， OKAMOTO Y， ROCHA V Z， et al. Inflammation in atherosclerosis： transition from theory to practice［J］. Circ J， 2010， 74（2）：213-220.
31	TROUBAT R， BARONE P， LEMAN S， et al. Neuroinflammation and depression： A review［J］. Eur J Neurosci， 2021， 53（1）：151-171.
32	LU H， YANG Q， ZHANG Y. The relation of common inflammatory cytokines with anxiety and depression and their values in estimating cardiovascular outcomes in coronary heart disease patients［J］. J Clin Lab Anal， 2022， 36（6）：e24404.
33	梁思宇，李向平，黄文钰，等. 冠心病合并焦虑和/或抑郁情绪患者血清髓过氧化物酶和脂氧素A4水平的变化［J］. 中南大学学报（医学版），2013，38（4）：370-375.
34	YANG X J， ZHAO B C， LI J， et al. Serum NLRP3 Inflammasome and BDNF： Potential Biomarkers Differentiating Reactive and Endogenous Depression［J］. Front Psychiatry， 2022， 13：814828.
35	DUMAN R S， SANACORA G， KRYSTAL J H. Altered Connectivity in Depression： GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments［J］. Neuron， 2019， 102（1）：75-90.
36	TROUBAT R， BARONE P， LEMAN S， et al. Neuroinflammation and depression： A review［J］. Eur J Neurosci， 2021， 53（1）：151-171.
37	宋风华，郑颖颖，唐俊楠，等. 平均血小板体积/淋巴细胞比值与冠心病经皮冠状动脉介入治疗术后长期死亡率的关系：一项队列研究［J］.实用医学杂志，2020，36（24）：3353-3357.
38	GEISER F， URBACH A S， HARBRECHT U， et al. Anxiety and depression in patients three months after myocardial infarction： Association with markers of coagulation and the relevance of age［J］. J Psychosom Res， 2017， 99：162-168.
39	SESHADRI N， ROBINSON K. Homocysteine and coronary risk［J］. Curr Cardiol Rep， 1999， 1（2）：91-98.
40	DEHARO P， MARLINGE M， GUIOL C， et al. Homocysteine concentration and adenosine A2A receptor production by peripheral blood mononuclear cells in coronary artery disease patients［J］. J Cell Mol Med， 2020， 24（16）：8942-8949.
41	GHAZIZADEH-HASHEMI F， BAGHERI S， ASHRAF-GAN-JOUEI A， et al. Efficacy and safety of sulforaphane for treatment of mild to moderate depression in patients with history of cardiac interventions： A randomized， double-blind， placebo-controlled clinical trial［J］. Psychiatry Clin Neurosci， 2021， 75（8）：250-255.
42	SIEGEL A N， RODRIGUES N， NASRI F， et al. Novel therapeutic targets in mood disorders： Pentoxifylline （PTX） as a candidate treatment［J］. Prog Neuropsychopharmacol Biol Psychiatry， 2021， 104：110032.
43	YASREBI S O， MOMTAZMANESH S， MOGHADDAM H S， et al. Pentoxifylline for treatment of major depression after percutaneous coronary intervention or coronary artery bypass grafting： A randomized， double-blind， placebo-controlled trial［J］. J Psychosom Res， 2021， 150：110635.
44	WANG B， TENG Y， LI Y， et al. Evidence and Characteristics of Traditional Chinese Medicine for Coronary Heart Disease Patients With Anxiety or Depression： A Meta-Analysis and Systematic Review［J］. Front Pharmacol， 2022， 13：854292.
45	CHEN M， ZHONG G， MEN L， et al. Effectiveness and safety of Xinkeshu on coronary artery disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention： A protocol for systematic review and meta-analysis［J］. Medicine （Baltimore）， 2021， 100（46）：e27912.
46	ZHANG Y Q， GUO Q Y， LI Q Y， et al. Main active constituent identification in Guanxinjing capsule， a traditional Chinese medicine， for the treatment of coronary heart disease complicated with depression［J］. Acta Pharmacol Sin， 2018， 39（6）：975-987.
47	DENG F， LI X， TANG C， et al. Mechanisms of Xiong-Pi-Fang in treating coronary heart disease associated with depression： A systematic pharmacology strategy and in vivo pharmacological validation［J］. J Ethnopharmacol， 2022， 298：115631.
48	LI Z， ZHANG J， QIAO M， et al. Efficacy and safety of Shugan Jieyu Decoction in the treatment of coronary heart disease complicated with depression［J］. Medicine （Baltimore）， 2023， 102（11）：e33176.
49	HU Y， LIU X， ZHANG T， et al. Behavioral and Biochemical Effects of KXS on Postmyocardial Infarction Depression［J］. Front Pharmacol， 2020， 11：561817.
50	AKOSILE W， TIYATIYE B， COLQUHOUN D， et al. Management of depression in patients with coronary artery disease： A systematic review［J］. Asian J Psychiatr， 2023， 83：103534.
51	LI Y N， BUYS N， FERGUSON S， et al. Effectiveness of cognitive behavioral therapy-based interventions on health outcomes in patients with coronary heart disease： A meta-analysis［J］. World J Psychiatr， 2021， 11（11）： 1147-1166.
52	WANG L， SUN Y， ZHAN J， et al. Effects of Exercise Therapy on Anxiety and Depression in Patients With Coronary Heart Disease： A Meta-Analysis of a Randomized Controlled Study［J］. Front Cardiovasc Med， 2021， 8：730155.
53	LIU J， YU P， LV W， et al. The 24-Form Tai Chi Improves Anxiety and Depression and Upregulates miR-17-92 in Coronary Heart Disease Patients After Percutaneous Coronary Intervention［J］. Front Physiol， 2020， 11：149.
54	GU H， LIU Z， ZHOU L. Roles of miR-17-92 Cluster in Cardiovascular Development and Common Diseases［J］. Biomed Res Int， 2017， 2017：9102909.
55	LI X X， FAN Z J， CUI J， et al. Cardiac rehabilitation of Baduanjin exercise in coronary heart disease after PCI： A protocol for systematic review and meta-analysis of randomized controlled trials［J］. Medicine （Baltimore）， 2021， 100（15）：e25501.
56	ADITI DEVI N， PHILLIP M， VARAMBALLY S， et al. Yoga as a monotherapy alters proBDNF - mature BDNF ratio in patients with major depressive disorder［j］. Asian J Psychiatr， 2023， 81：103429.
57	张健真，吴焕林，常佩芬，等.微砭耳针对经皮冠状动脉介入术后伴焦虑状态患者的疗效观察［J］.针刺研究，2021，46（10）：880-884.
58	AKOSILE W， TIYATIYE B， COLQUHOUN D， et al. Management of depression in patients with coronary artery disease： A systematic review［J］. Asian J Psychiatr， 2023， 83：103534.

[1]	Qing ZHANG,Tudi LI,Rong CHEN,Zhihuan. ZENG. Research progress on sodium⁃glucose cotransporter 2 inhibitors for in⁃stent restenosis after percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2024, 40(8): 1175-1180.
[2]	Yue REN,Ting TIAN,Guangsheng WEI,Ming ZHANG,Hong YU,Jie LI,Tingting DONG,Yinmei FENG,Hongchao CUI,Jiao. ZHANG. Effect of stage I comprehensive cardiac rehabilitation in patients with acute ST elevation myocardial infarctionafter emergency percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2024, 40(5): 682-687.
[3]	Jianlong SHENG,Ni′na. LIU. The advanced progress on the relationship between hyperuricemia and acute myocardial infarction [J]. The Journal of Practical Medicine, 2024, 40(5): 727-730.
[4]	Rui XU,Xingbing. HUANG. Progress of non-pharmacological treatments for treatment-resistant depression [J]. The Journal of Practical Medicine, 2024, 40(4): 439-446.
[5]	Kanglin CAI,Jinkai ZHANG,Liangdi RAN,Dajun HU,Zhitao FENG,Huilian. HUANG. Research progress on antidepressant pharmacological effects and mechanisms of Bupleuri Radix⁃Paeoniae Radix Alba herb⁃pair [J]. The Journal of Practical Medicine, 2024, 40(4): 447-452.
[6]	Yonghui LIU,Qingjing TAN,Qing CHEN,Liping WEI,Junwei YANG,Kan YANG,Yuguang. GAO. The mechanism of target regulating of miR⁃421 to Menin/Caspase⁃3 pathway for depression [J]. The Journal of Practical Medicine, 2024, 40(4): 453-459.
[7]	Wenjie HAN,Youtian ZHOU,Zhensheng LI,Jianjie KANG,Bingmei. DENG. Risk factors of depression and anxiety in epilepsy patients and their relationship with quality of life [J]. The Journal of Practical Medicine, 2024, 40(4): 460-465.
[8]	Li LI,Lin. TANG. Analysis of influencing factors of non⁃suicidal self⁃injury behavior and motivation in adult patients with depression [J]. The Journal of Practical Medicine, 2024, 40(4): 466-470.
[9]	Xiaojie DONG,Peng WANG,Junhua MA,Jian WANG,Chuandong YAN. Correlation analysis between personality traits and non suicidal self injury behavior in adolescent depression patients [J]. The Journal of Practical Medicine, 2024, 40(20): 2848-2853.
[10]	Qian ZHAO,Yan ZHANG,Qiao QIAO,Aiyun DENG. Prognostic factors of patients undergoing percutaneous coronary intervention supported by extracorporeal membrane oxygenation [J]. The Journal of Practical Medicine, 2024, 40(2): 219-224.
[11]	Jiawu FU,Hao WU,Zhimin LIAO,Jing CHEN,Junliang. LI. Association between miRNA-146a gene polymorphisms and ischemic post-stroke depression [J]. The Journal of Practical Medicine, 2024, 40(19): 2708-2712.
[12]	Fengxia QU,Yue XIN,Jingyuan LI,Xiao GUO,Changhong. LU. Evaluation of the efficacy of Internet+cardiac rehabilitation intervention in patients with hypertension and coronary heart disease [J]. The Journal of Practical Medicine, 2024, 40(19): 2778-2782.
[13]	Shuping GE,Wei CHEN,Xinxin JIA,Min GAO,Min HE,Cunyu. QIN. Effect of individual exercise training as the core cardiac rehabilitation program on the rehabilitation of patients with coronary heart disease after percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2024, 40(18): 2607-2611.
[14]	Hongmei LIU,Huahong ZHOU,Xiangjiu CHEN,Guobao HONG,Xiongbin WU,Yanjuan LIANG,Chunting LI,Meidi ZHENG,Yueqin LAI,Fanna. LIU. Association of frailty with anxiety and depression in patients on maintenance hemodialysis [J]. The Journal of Practical Medicine, 2024, 40(18): 2612-2617.
[15]	Yalin YANG,Yang HU,Yunhong WEI,Jie DENG,Yu. WANG. Application value and progress of heart rate recovery in indication of cardiovascular diseases [J]. The Journal of Practical Medicine, 2024, 40(18): 2660-2664.

Mechanisms and treatments of post⁃PCI anxiety and depression of patients with coronary heart disease： A review of literature

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 58

Related Articles 15

Recommended Articles

Metrics

Comments